Safety and efficacy of n-3 fatty acid-based parenteral nutrition in patients with obstructive jaundice: a propensity-matched study

Qiong Gong, Peng Zhu, Binhao Zhang, Chang Shu, Zeyang Ding, Jingjing Wu, Bixiang Zhang, Xiao-Ping Chen, Qiong Gong, Peng Zhu, Binhao Zhang, Chang Shu, Zeyang Ding, Jingjing Wu, Bixiang Zhang, Xiao-Ping Chen

Abstract

Background: It is reported that lipid emulsion enriched in n-3 fatty acids (FAs) helps us to improve postoperative recovery for surgical patients with biliary tract disease. Its role for postoperative patients with obstructive jaundice is as yet unclear. The object of this study was to evaluate the safety and efficacy of n-3 fatty acid-based parenteral nutrition (PN) for patients with obstructive jaundice following surgical procedures.

Methods: Data were collected from patients with obstructive jaundice who received PN, including n-3 PUFA-enriched lipid emulsions and standard non-enriched lipid emulsions (e.g., soybean oil). We then calculated a propensity score, the probability of receiving different PN, by the propensity score matched (PSM) method. After matching, we compared isonitrogenous total PN with 20% Structolipid and 10% n-3 fatty acid (Omegaven, Fresenius-Kabi, Germany) (treatment group) to Structolipid alone (control group) for 5 days postoperatively, in the absence of enteral nutrition.

Results: Before the propensity score matching, there were 226 patients enrolled. After propensity score stratification, 108 cases remained, and all covariates were balanced. Among matched patients with PN, patients in the control group were at a higher risk for long-term jaundice recovery (12.9 ± 8.5 VS 16.4 ± 7.9 P = 0.029), lower velocity of reduction in jaundice (P = 0.045), and lower pre-albumin (P = 0.002). No significant difference as found in terms of comorbidities, white blood cell (WBC), albumin and other aspects.

Conclusion: PN with n-3 PUFA-enriched lipid emulsions was safe and effective in accelerating jaundice recovery for patients after surgical procedures. This trial was registered at clinicaltrials.gov as NCT03376945.

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Flow chart of cohort (It shows the process of screening the patients treated or untreated with n-3 FA in the initial and final propensity score matched sample. We screened a total of 827 patients with obstructive jaundice in Tongji Hospital between May 2014 and June 2017. Finally, 108 cases were enrolled into the PSM cohort for the last statistical calculation)
Fig. 2
Fig. 2
The differences of inflammatory reaction between two groups after operation. There were no differences in WBC or GRAN between two groups (P = 0.943, P = 0.410), respectively
Fig. 3
Fig. 3
During the postoperative period, patients in the n-3 group had rapid jaundice recovery (a) (P = 0.045), shorter duration of the jaundice recovery (b) (P = 0.029), lower cholesterol (c) (P = 0.045) and higher pre-albumin (d) (P = 0.002),

References

    1. Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med. 1999;27:1409–20. doi: 10.1097/00003246-199908000-00001.
    1. Clugston A, Paterson HM, Yuill K, Garden OJ, Parks RW. Nutritional risk index predicts a high-risk population in patients with obstructive jaundice. Clin Nutr. 2006;25:949–54. doi: 10.1016/j.clnu.2006.03.001.
    1. Gouma DJ, Roughneen PT, Kumar S, Moody FG, Rowlands BJ. Changes in nutritional status associated with obstructive jaundice and biliary drainage in rats. Am J Clin Nutr. 1986;44:362–9. doi: 10.1093/ajcn/44.3.362.
    1. Padillo FJ, Andicoberry B, Naranjo A, Mino G, Pera C, Sitges-Serra A. Anorexia and the effect of internal biliary drainage on food intake in patients with obstructive jaundice. J Am Coll Surg. 2001;192:584–90. doi: 10.1016/S1072-7515(01)00841-9.
    1. Horvatits T, Drolz A, Rutter K, Roedl K, Langouche L, Van den Berghe G, et al. Circulating bile acids predict outcome in critically ill patients. Ann Intensive Care. 2017;7:48. doi: 10.1186/s13613-017-0272-7.
    1. Zhang B, Wei G, Li R, Wang Y, Yu J, Wang R, et al. n-3 fatty acid-based parenteral nutrition improves postoperative recovery for cirrhotic patients with liver cancer: a randomized controlled clinical trial. Clin Nutr. 2017;36:1239–44. doi: 10.1016/j.clnu.2016.08.002.
    1. Hughes MJ, McNally S, Wigmore SJ. Enhanced recovery following liver surgery: a systematic review and meta-analysis. HPB: Off J Int Hepato Pancreato Biliary Assoc. 2014;16:699–706. doi: 10.1111/hpb.12245.
    1. Plusa S, Webster N, Primrose J. Obstructive jaundice causes reduced expression of polymorphonuclear leucocyte adhesion molecules and a depressed response to bacterial wall products in vitro. Gut. 1996;38:784–7. doi: 10.1136/gut.38.5.784.
    1. Koller M, Senkal M, Kemen M, Konig W, Zumtobel V, Muhr G. Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery. Clin Nutr. 2003;22:59–64. doi: 10.1054/clnu.2002.0592.
    1. Sorensen LS, Thorlacius-Ussing O, Schmidt EB, Rasmussen HH, Lundbye-Christensen S, Calder PC, et al. Randomized clinical trial of perioperative omega-3 fatty acid supplements in elective colorectal cancer surgery. Br J Surg. 2014;101:33–42. doi: 10.1002/bjs.9361.
    1. Bozzetti F, Braga M, Gianotti L, Gavazzi C, Mariani L. Postoperative enteral versus parenteral nutrition in malnourished patients with gastrointestinal cancer: a randomised multicentre trial. Lancet (Lond, Engl) 2001;358:1487–92. doi: 10.1016/S0140-6736(01)06578-3.
    1. Llop-Talaveron JM, Badia-Tahull MB, Leiva-Badosa E, Ramon-Torrel JM. Parenteral fish oil and liver function tests in hospitalized adult patients receiving parenteral nutrition: a propensity score-matched analysis. Clin Nutr. 2017;36:1082–8. doi: 10.1016/j.clnu.2016.06.027.
    1. Mizuguchi T, Kawamoto M, Meguro M, Hui TT, Hirata K. Preoperative liver function assessments to estimate the prognosis and safety of liver resections. Surg Today. 2014;44:1–10. doi: 10.1007/s00595-013-0534-4.
    1. Juntermanns B, Sotiropoulos GC, Radunz S, Reis H, Heuer M, Baba HA, et al. Comparison of the sixth and the seventh editions of the UICC classification for perihilar cholangiocarcinoma. Ann Surg Oncol. 2013;20:277–84. doi: 10.1245/s10434-012-2486-0.
    1. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13. doi: 10.1097/.
    1. Licata LA, Nguyen CT, Burga RA, Falanga V, Espat NJ, Ayala A, et al. Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils. J Leukoc Biol. 2013;94:813–23. doi: 10.1189/jlb.0313137.
    1. Popovic T, Ranic M, Bulajic P, Milicevic M, Arsic A, Vucic V, et al. Effects of n-3 fatty acids supplementation on plasma phospholipids fatty acid composition in patients with obstructive jaundice—a pilot study. J Clin Biochem Nutr. 2009;45:370–5. doi: 10.3164/jcbn.09-54.
    1. Grossman Y, Barbash IM, Fefer P, Goldenberg I, Berkovitch A, Regev E, et al. Addition of albumin to traditional risk score improved prediction of mortality in individuals undergoing transcatheter aortic valve replacement. J Am Geriatr Soc. 2017;65:2413–7. doi: 10.1111/jgs.15070.
    1. Grimble R. Fatty acid profile of modern lipid emulsions: scientific considerations for creating the ideal composition. Clin Nutr Suppl. 2005;1:9–15. doi: 10.1016/j.clnu.2005.05.009.
    1. Weimann A, Braga M, Carli F, Higashiguchi T, Hubner M, Klek S, et al. ESPEN guideline: clinical nutrition in surgery. Clin Nutr. 2017;36:623–50. doi: 10.1016/j.clnu.2017.02.013.
    1. Braga M, Ljungqvist O, Soeters P, Fearon K, Weimann A, Bozzetti F. ESPEN guidelines on parenteral nutrition: surgery. Clin Nutr. 2009;28:378–86. doi: 10.1016/j.clnu.2009.04.002.
    1. Heller AR, Rossler S, Litz RJ, Stehr SN, Heller SC, Koch R, et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med. 2006;34:972–9. doi: 10.1097/01.CCM.0000206309.83570.45.
    1. Wichmann MW, Thul P, Czarnetzki HD, Morlion BJ, Kemen M, Jauch KW. Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion: data from a prospective, randomized, multicenter trial. Crit Care Med. 2007;35:700–6. doi: 10.1097/.
    1. Ferguson JF, Mulvey CK, Patel PN, Shah RY, Doveikis J, Zhang W, et al. Omega-3 PUFA supplementation and the response to evoked endotoxemia in healthy volunteers. Mol Nutr Food Res. 2014;58:601–13. doi: 10.1002/mnfr.201300368.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren